Prognostic Value of Surem TRAF3IP2 Level in Patients With Acute Myocardial Infarction

Nanjing Medical University

Status: Enrolling

Conditions: Myocardial Infarction, Acute

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT06038994

20230901

Details and patient eligibility

About

To evaluate the prognostic value of surem TRAF3IP2 levels in patients with acute myocardial infarction

Full description

Previous study had concluded that TRAF3IP2 plays a causal role in atherosclerotic plaque development and vulnerability in mice. However, no human data was available. In the present study, patients diagnosed with acute myocardial infarction who receive coronary angiography will be enrolled. Their surem TRAF3IP2 levels will be tested using ELASA. The association of surem TRAF3IP2 levels with the major adverse cardiac events will be evaluated.

Enrollment: 200 estimated patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients with acute myocardial infarction
2. patients received coronary angiography
3. invasive management within 72 h of hospital admission

Exclusion criteria

1. NYHA III-IV
2. malignant tumor
3. acute infection
4. thyroid dysfunction
5. Life expectancy of b1 y
6. Unsuitable for PCI

Trial design

200 participants in 1 patient group

Patients with acute myocardial infarction who experienced CAG

Description:

Patients with acute myocardial infarction who experienced coronary angiography

Treatment:

Other: No intervention